NCT03824990

Multi-center Clinical Study on Neonatal Hyperbilirubinemia

Multi-center Clinical Study on Early Screening and Treatment of Hyperbilirubinemia of Term and Late-preterm Neonates

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20,000 (actual)
• Sponsor: Nanjing Medical University · Academic / Other
• Sex: All
• Age: 1 Day – 28 Days
• Healthy volunteers: Not accepted

Summary

Eight hospitals in China will participate in the study, which aims to decrease the incidence of severe hyperbilirubinemia.

Detailed description

Through a prospective cohort study of healthy term and near-term infants, the study tries to truly reflect the epidemiology, intervention status, and outcomes of neonatal hyperbilirubinemia and the cost. Hopefully, by improving the quality of management of neonatal jaundice,we can explore and obtain a healthy term and near-term jaundice management model suitable for China's national condition, which can eventually reduce the incidence rate of neonatal severe hyperbilirubinemia and bilirubin encephalopathy.

Conditions

• Quality Improvement
• Hyperbilirubinemia, Neonatal

Interventions

Type	Name	Description
BEHAVIORAL	Quality improvement of management of neonatal jaundice	During the Intervention phase and Sustainability phase ,The hospitals will receive training of multiple evidence based quality improvement methods.

Timeline

• Start date: 2018-03-01
• Primary completion: 2021-08-31
• Completion: 2021-10-15
• First posted: 2019-01-31
• Last updated: 2021-11-01

Locations

1 site across 1 country: China